Newsletter
Newsletter Support JNS

Former Israeli prime minister Barak appointed chair of medical marijuana company

In a statement, InterCure said Ehud Barak’s “stature” will be helpful for the company’s development.

Former Israeli Prime Minister Ehud Barak at the Saint Petersburg Economic Forum in 2015. Credit: Ministry of Digital Development, Communications and Mass Media of the Russian Federation.
Former Israeli Prime Minister Ehud Barak at the Saint Petersburg Economic Forum in 2015. Credit: Ministry of Digital Development, Communications and Mass Media of the Russian Federation.

Former Israeli Prime Minister Ehud Barak will chair the Israeli medical marijuana company InterCure, according to the firm, which made the announcement on Wednesday.

Barak served as defense minister and then prime minister in the early 2000s. He has remained in the public spotlight since leaving politics, usually criticizing current government policies.

InterCure said that Barak will head its global growth initiative. In a statement, the company said Barak’s “stature” will be helpful for the company’s development.

Barak will work 40 monthly hours for $10,000 per month. He will also be eligible for stock options, according to the company.

InterCure, publicly traded in Israel, is expected to change its name to Canndoc Pharma.

The Berkeley project “has a record of promoting anti-Israel and antisemitic agendas,” Oleg Ivanov, of StandWithUs, told JNS. “We are deeply concerned that the same thing will happen in this training.”
The Federation told JNS exclusively that it is ending its engagement with a consultant who headed one of its communications projects after JNS reported that he advised attendees at a Federations conference to avoid using the word “Zionism.”
The U.S. president insists that American naval forces are maintaining a strict blockade until Tehran agrees to a deal or total surrender.
Mahmoud Fatair was a Palestinian Islamic Jihad Nukhba commander who infiltrated Israel on Oct. 7, 2023.